HANALL BIOPHARMA CO.,LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 009420 for the last quarter is 36.84 B KRW, and it's 16.61% higher compared to the previous quarter. The net income of Q3 24 is 222.00 M KRW.